---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038430"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:55:01.134743+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Second Amendment to Merger Agreement reduces independent director requirement for SBC designees from two to one

## Summary
- Amendment dated Oct 26, 2023 modifies Section 5.17(a) of the Merger Agreement regarding post-closing board composition.
- SBC now needs only one independent director among its three designees, down from two previously.
- Pono's sole designee must now qualify as an independent director (previously no independence requirement).
- The mutual designee (Pono and SBC) must still be independent.

## SEC filing metadata
- accession: 0001493152-23-038430
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000149315223038430/0001493152-23-038430-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000149315223038430/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038430
- JSON: https://secwatch.observer/filing/0001493152-23-038430.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038430.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.